← All Stocks
pharma

AMGN — Amgen Inc.

Conviction51
Congress 90d1
Insider 90d0
Markets0
Lobbying10
Contracts1
CountryUS

AMGN

Amgen Inc.

pharma
51thin · 2 src▲ Bullish2 sources agree
🏛 Congress📋 Lobbying

Congressional trades

Last 90 days
1 buy0 sell1 legislator
  • buy David J. Taylor$1K–$15K · Jun 5, 2026
All trades →

Prediction markets

No prediction markets reference this stock.

Lobbying filings

Last 2 years
  • ALPINE GROUP PARTNERS, LLC.$50K · 2026 first_quarter
    MMMTAXTRD
  • OGR$50K · 2026 first_quarter
    MMMTAX
  • CAPITOL COUNSEL LLC$50K · 2026 first_quarter
    MMM
  • SIGHTLINE ADVOCACY, LLC$20K · 2026 first_quarter
    HCR
  • EMPIRE CONSULTING GROUP$50K · 2026 first_quarter
    HCR
  • TIBER CREEK GROUP$60K · 2026 first_quarter
    HCRMMM
  • JEFFREY J. KIMBELL & ASSOCIATES, INC.$8K · 2026 first_quarter
    HCR
  • FORBES-TATE$80K · 2026 first_quarter
    BUDMEDMMMTAX
  • S-3 GROUP$60K · 2026 first_quarter
    BUDHCR
  • MARSHALL & POPP, LLC$60K · 2026 first_quarter
    CPTPHATRD

Country exposure

Domicile · not revenue geography

Approximated from company domicile — not revenue-by-geography.This panel maps the ticker to a single country using the company's registered domicile, a static lookup. It does not reflect where the company actually earns revenue or carries operational exposure (e.g. a US-domiciled chipmaker may have most of its real exposure in Taiwan or China).

🇺🇸 United States59/100
Posture: neutralView United States →

Insider activity

No insider transactions filed in the last 90 days.

Federal contracts

$773.9M · 0% defense
  • Department of Health and Human Services$773.9M · Sep 30, 2022
v·3485b22